Venkata Lokesh Battula, Professor at VCU Massey Comprehensive Cancer Center, shared on LinkedIn:
“New review out in Frontiers in Immunology!
Our lab just published “B7-H3 (CD276): An Actionable Therapeutic Target and Prognostic Biomarker Across Human Malignancies“, covering B7-H3’s biology as an immune checkpoint and the fast-growing pipeline of therapies targeting it (ADCs, bispecifics, CAR-T/NK, and more).
Proud of this work with co-authors Dayna Smith and Dr. Anudishi Tyagi, and grateful for the support of VCU Massey Comprehensive Cancer Center.”
Title: B7-H3 (CD276): an actionable therapeutic target and prognostic biomarker across human malignancies
Authors: Dayna Smith, Anudishi Tyagi, Venkata Lokesh Battula.
Other articles about VCU Massey Comprehensive Cancer Center on OncoDaily.